A Retrospective Analysis of Clinical and Laboratory Data of Patients with Factor VII Deficiency: A Single Centre Experience.
In conclusion, the clinical picture of the analysed group is similar to the previously described. It should be stressed that a significant risk of bleeds, including joint haemorrhages, can be expected in patients with mildest FVII deficiency (>26%) as well. The rate of thrombosis (4.7%) was similar to other reports, with all affected patients having strong prothrombotic risk factors or being intensively treated with FVII concentrate.
PMID: 31364092 [PubMed - as supplied by publisher]
Source: Hamostaseologie - Category: Hematology Authors: Iwaniec T, Zdziarska J, MusiaĆ J, Sanak M Tags: Hamostaseologie Source Type: research
More News: Bleeding | Haemophilia | Hematology | Hemophilia | Laboratory Medicine | Orthopaedics | Poland Health | Study | Thrombosis | Women